Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGA-3: Efficacy and Safety of Phentolamine Ophthalmic Solution in Presbyopia
NCT06542497Phase 3Completed
- Sponsor
- Opus Genetics
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
A Phase 3 trial of phentolamine in presbyopia, sponsored by Opus Genetics. Started Aug 2024; status: completed.
02
Drugs
phentolamine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT06542497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06542497.